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Background: The aim of this study was to analyze and describe the epidemiological characteristics and trends of
lung cancer in North Sardinia, Italy, in the period 1992–2010.
Methods: Data were obtained from the tumor registry of Sassari province which is a part of a wider registry web,
coordinated today by the Italian Association for Tumor Registries.
Results: The overall number of lung cancer cases registered was 4,325. The male-to-female ratio was 4.6:1 and the
mean age 68.1 years for males and 67 years for females. The standardized incidence rates were 73.1/100,000 and
13.5/100,000 and the standardized mortality rates 55.7/100,000 and 9.9/100,000 for males and females, respectively.
An increasing trend in incidence of lung cancer in women was evidenced. Conversely, incidence was found to
decrease in males. Relative survival at 5 years from diagnosis was low (8.8% for males and 14.9% for females).
Furthermore, an increase in mortality rates was observed in both sexes in the period under investigation.
Conclusions: Our data show an increasing trend of lung cancer incidence in women in North Sardinia in the last
decades. Conversely, a reduction of incidence rates was observed in males. Furthermore, a slightly increasing trend
in mortality rates was observed in both sexes, suggesting the need to enhance smoking control strategies, consider
adoption of effective surveillance policies, and improve diagnosis and treatment methods.
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Lung cancer is the most common neoplastic disease in
the world with more than 1,600,000 cases estimated in
2008 [1]. Considering world incidence rates, lung cancer
ranks first in men and fourth in women after breast, cer-
vix uteri and colorectal cancer [1]. It also represents the
most frequent neoplastic cause of death worldwide [1].
A consistent increase in lung cancer incidence was
recently registered in developing countries and in
women, while it began to decline in males in most
Western countries [2,3]. These trends reflect primarily
the continuous changes in smoking habits and envir-
onmental pollution, particularly in developing coun-
tries, as well as the progressive improvement of life
expectancy in Western countries. Since the first rele-
vant publications in the fifties of the past century, it
has been evidenced that smoking is the risk factor* Correspondence: cossu@uniss.it
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distribution, and reproduction in any mediumthat mostly impacts the epidemiological trends of lung
cancer [4,5]. Even if other factors such as workplace
exposure to pollution and genetic determinants were
evidenced to contribute to lung carcinogenesis, active and
passive smoking remain the most incident risk factor. This
induced the adoption of smoking control campaigns,
especially in developed countries, which recently lead to
progressive reduction of lung cancer incidence and mor-
tality in males in these countries.
The aim of this population-based study was to analyze
and describe the epidemiological characteristics and
trends of lung cancer in north Sardinia, Italy, in the
period 1992–2010.Methods
The epidemiological data presented in this article
were obtained from the “Registry of the tumors of
the Province of Sassari”. This registry was created in
1992 by the local health agency for the epidemio-
logical surveillance of tumors in that province. In
1999 it became part of a wider web of tumorntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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for Tumor Registries (AssociazioneItalianaRegistriTumori,
AIRTUM). The association coordinates 34 registries in
the country, collects and publishes data, and collaborates
with international organizations in the field.
Every registry collects data on tumoral diseases affect-
ing inhabitants in the territory of jurisdiction through
the local hospitals and health care services, as with other
registries (e.g., death registries). Demographic, clinical,
pathological and prognostic data are collected for each
case of cancer and are registered in a digital database.
This database was the data source for the present
population-based report.
The demographic characteristics of the patients af-
fected by lung cancer were collected. Crude incidence
and mortality rates per 100,000 inhabitants per year
were calculated, and the standardized rates were ad-
justed for European age-population standards. Further-
more, time trends of incidence rates by age class and
gender were studied, as well as the estimated change in
annual percentage. A comparison between incidence and
mortality in the province of Sassari and those in other
Italian provinces was also performed. In addition, the
cumulative risk of developing the disease and of dying
between zero and 74 years of age was estimated. The age
class distribution and time trends of incidence, mortality,
mean age of disease onset and death, and histology were
evaluated. Finally, relative 5-year survival was calculated
by the Hakulinen method.
Results
The overall number of cases of lung cancer registered in
the period 1992 – 2010 was 4,325. The diagnosis was
obtained by histological or cytological reports in 3,178
cases (73.5%) and using other information sources
(clinical reports, radiological referrals, death certifica-
tions, etc.) in 1,129 cases (26.1%). The modality of
diagnosis was not known in 18 cases (0.4%). Among
the 4,284 individuals registered, 3,554 were males and
771 females, with a male-to-female ratio of 4.6:1. The
mean age was 68.1 years for males and 67 years for
females. The cumulative risk of developing the disease
was 6.13% for males and 1.11% for females.
With regard to the anatomical distribution of the tu-
mors 568 (13.1%) were located in the tracheo-bronchial
tree, 1,493 (34.5%) in the upper lobes, 231 (5.3%) in the
right middle lobe, 781(18.1%) in the inferior lobes and
272 (6.3%) in more than one lobe, while in 980 (22.7%)
cases the anatomical localization was not known.
Among the 3,178 tumors that had histological or cyto-
logical diagnosis, 1,330 (41.9%) were adenocarcinomas,
845 (26.6%) were squamous cell carcinomas, 310 (9.8%)
were small cell cancers, 88 (2.8%) were large cell cancers
and 126 (4%) were other histotypes, while in theremaining 479 (15%) cases the exact histologic type was
not specified. The percentages of adenocarcinomas were
42.2% and 40.1% respectively in males and females with
known histology, while the corresponding figures for
squamous cell carcinomas were 26.4% and 27.4%. Fur-
thermore, no significant differences in the distribution of
other rarer histological subtypes among sexes were
found. Figure 1 depicts the global trends of the principal
histotypes in the years under investigation.
The crude incidence of lung malignancies in the
period under investigation was 86.5/100,000 for men
and 18.1/100,000 for women. Standardized incidence
rates were 73.1/100,000 for males and 13.5/100,000 for
females.
Table 1 shows the percent distribution of incidence in
relation to age, while Table 2 shows the distribution of
incidence rates in relation to age. Peak incidence oc-
curred at 75–79 years for both males and females. Inci-
dence rates were also calculated for the following three
time periods: 1992–1998, 1999–2004 and 2005–2010
(Figure 2). There was a progressive decrease in incidence
rates in males, from 78.7/100,000 in the first period, to
72.3/100,000 in the second period and 67.3/100,000 in
the last period. The corresponding figures for females
were 10.1/100,000, 13.5/100,000 and 17.4/100,000,
respectively. Figures 3 and 4 illustrate the trends of inci-
dence by age-class and gender. A constant increase in
incidence occurred between 1992 and 2010 in women,
especially those older than 45 years. No significant
changes in incidence were evidenced in younger age
groups in both sexes. The estimated annual percentage
change in males was −0.19, −1.53, -4, and −0.04 for 30–
44, 45–59, 60–74, ≥75 age groups respectively. The cor-
responding figures in women were 0.09, 0.5, 0.46, and
0.44. Analysis of the trend of mean age at disease onset
for the same periods of time did not reveal any relevant
changes. Table 3 shows the comparison of the incidence
and mortality in the province of Sassari with those in
other Italian provinces.
There were 3,347 deaths in the period under investiga-
tion (2,751 males and 596 females). Crude overall mor-
tality was 67/100,000 for males and 14/100,000 for
females. Mean age at death was 69.4 years in males and
69.2 years in females. Standardized mortality rates were
55.7/100,000 for males and 9.9/100,000 for females. The
cumulative risk of death was 4.47% for males and 0.78%
for females. Table 2 shows the age-class distribution of
mortality rates. There was a relevant increase in mortal-
ity rates after the fifth decade of life. Figure 2 shows the
time trend of mortality between 1992 and 2010: a signifi-
cant increase in mortality in both sexes was registered.
Finally, relative survival at 5 years from diagnosis was
10% (8.8% for males and 14.9% for females). Relative 5-
years survival was 9.3% in the period 1992–1998, 10.4%
Figure 1 Trends in histological subtypes of lung cancer in North Sardinia, 1992–2010.
Table 2 Age-class incidence and mortality rates of lung





Males Females Males Females
0-4 0 0 0 0
5-9 0 0 0 0
10-14 0 0 0 0
15-19 0 0 0 0
20-24 0 0.4 0 0
25-29 0.6 0.3 0 0
30-34 1.8 1.8 1.5 0.6
35-39 3.9 3.9 2.1 1.5
40-44 12.9 4.4 6.9 3.5
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under investigation (2005–2010).
Discussion
World population age-standardized incidence of lung
cancer calculated in 2008 was 22.9/100,000 (33.8/
100,000 for men and 13.5/100,000 for women), while
cumulative risk was 2.77% [1]. Lung cancer is also the
most frequent cause of death for cancer, with more than
1,370,000 deaths in the world in the same year [1].
The incidence of lung cancer is significantly higher in
most industrialized areas worldwide in comparison with
developing countries; however, these countries present
continuously increasing incidences in the last decades
[1,6]. In Europe more than 380,000 cases of lung cancer
were estimated in 2008, with a standardized incidence
rate of 48.9/100,000 for men and 13.4/100,000 for
women, and approximately 340,000 deaths, with stan-
dardized mortality rates of 42.5/100,000 for males and
10.8/100,000 for females. The highest figures were ob-
served in central and eastern European countries
(Hungary and Poland) [1].Table 1 Age-class incidence distribution of lung cancer in
North Sardinia, 1992-2010
Age (years) Number of cases (%)
Males Females
0-14 0 (0) 0 (0)
15-29 2 (0.06) 2 (0.26)
30-44 60 (1.69) 33 (4.28)
45-59 656 (18.46) 173 (22.44)
60-74 1,819 (51.18) 315 (40.86)
75+ 1,017 (28.62) 248 (32.17)In Italy 38,500 new cases and 34,500 deaths for
lung cancer were estimated in 2012 [7]. Different in-
cidence figures were observed throughout the country
in the period 2006–2008: 72.9/100,000 in northern,
63.8/100,000 in central and 65.4/100,000 in southern
regions [7]. The standardized incidence rates in the45-49 37.7 15.3 20.4 9.2
50-54 72.5 19.4 50.6 14.6
55-59 141.2 29.2 100,4 16.7
60-64 240.4 35.5 168.4 25.5
65-69 329.6 50.5 229.8 36.4
70-74 424.4 62.5 334.5 47.8
75-79 495.3 85.8 442.9 73.1
80-84 472 74 453.2 74.9
85+ 298.2 44.4 290.2 50.9
Total 86.5 18.1 67 14
Figure 2 Incidence and mortality rates trends of lung cancer in North Sardinia, 1992–2010.
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AIRTUM for northern Italian regions. Comparisons of
the incidence rates with those of other Italian prov-
inces or regions place our province in the middle
between those with low incidence rates, such as Alto
Adige and Macerata, and those with higher incidences
like Genoa, Ferrara and Veneto (Table 3). Lung can-
cer incidence rate was lower in North Sardinia than
average rate in Italy; this may be due to a minor ex-
posure to occupational and environmental carcinogensFigure 3 Age-class incidence rates trends of lung cancer in males in Nlike asbestos, arsenic, radon and polycyclic aromatic
hydrocarbons, given the lower diffusion of industrial
activities in the area in the last decades, in compari-
son to other Italian provinces [8].
Concerning histology, our data evidenced a prevalence
of adenocarcinomas over squamous cell carcinomas and
other subtypes of lung cancer. Furthermore, a decline in
incidence of squamous cell carcinomas was evidenced,
as opposed to other histological types which presented a
slight increase in incidence rates between 1992 andorth Sardinia, 1992–2010.
Figure 4 Age-class incidence rates trends of lung cancer in females in North Sardinia, 1992–2010.
Table 3 Comparison with incidence and mortality rates of





Males Females Males Females
Alto Adige 59 16.2 51.9 12.7
Biella 94 16.3 80.1 14
Ferrara 96.8 18.7 81.7 16.2
Florence 77.4 17.1 65.5 12.7
Friuli V.G. 78.8 19.2 71.5 16
Genoa 97.9 16.6 80.1 12.6
Macerata 64 11.9 57 8
Modena 82.9 18.6 72.9 15.4
Naples 94.8 13 83 10.6
Parma 80.8 20 65.2 14.9
Ragusa 65 8.4 56.6 7.3
Reggio Emilia 76.9 19 69.9 14.5
Romagna 87.7 20.3 71.5 14.5
Salerno 74.3 8.8 66.1 7.6
Sassari 73.1 13.5 55.7 9.9
Turin 87.9 18.2 75.7 14.2
Trento 68 11.8 66.6 10.7
Umbria 66.7 14.2 55.4 9.8
Varese 84.1 14.5 81.1 12
Veneto 95.1 21.1 85.7 15.5
Mean 80.8 16.9 69.9 13.1
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rates by histologic subtype occurred in the last decades.
Squamous cell carcinoma was the most frequently
observed histotype in the initial epidemiological reports
since the 80’s when it was superseded by adenocarcin-
oma [2,9]. The causes of such shifting are not clear and
several hypotheses have been proposed, concerning
mainly factors linked to tobacco smoking: changes in the
characteristics of cigarettes, increased puff volume,
increased nitrate levels and, finally, higher incidences in
women who tend to have adenocarcinomas more
frequently than parallel male cohorts [10,11]. This ten-
dency was not confirmed in our cohort in which adeno-
carcinomas and squamous cell carcinomas involved both
sexes similarly, but a relatively high percentage of cases
without histological diagnosis was also observed (15%),
due to some procedural limitations in data collection
and registration.
Considering the distribution of the disease in relation
to age, less than 5% of the cases occurred in individuals
<45 years, while more than 75% occurred after the sixth
decade of life. This reflects the modalities of exposure to
risk factors like smoking and pollution and the long
latency from exposure to disease. Incidence rates in-
creased with aging in both sexes, reaching peak values in
individuals ≥ 80 years. Incidence rates trends remained
stable in individuals <45 years, decreased in all age
groups in males ≥45 years (especially in the last decade),
and increased in the corresponding age groups in
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change by age group demonstrated that incidence rate
reductions in males and increases in females involved
mainly individuals between the fifth and seventh decade
of life. This distribution pattern is similar to those
reported for the world population [6].
The time trends analysis showed a steady increase in
incidence of lung cancer in females in Sassari province
in the period under investigation. Conversely, a slight
reduction in incidence rates was observed in males.
These trends are common to numerous national and
international geographical areas, and may reflect the
increasing diffusion of tobacco smoking in women as
opposed to the reduction of smoking incidence in men.
The world standardized incidence rates of lung cancer
increased by 22% among females and decreased by 3%
among males in the period 1985–2002 [12]. Giving the
current smoking trends, it is calculated that by 2030
lung cancer will affect both sexes equally [2].
The role of screening programs in patients with risk
factors for lung cancer is still a matter of debate. Some
studies, especially those performed using standard chest
X-ray, did not reveal any impact of the screening pro-
gram on survival. More recent contributions, with a lon-
ger follow up time available and better technologies
employed, showed a relevant decrease in mortality rates
in enrolled patients, and posed the question of the utility
of screening strategies in lung cancer prevention [13].
Nevertheless, several aspects remain to be addressed
before the introduction and diffusion of screening cam-
paigns in clinical practice. To date no screening pro-
grams for lung cancer are active in North Sardinia, as
opposed to numerous smoking control campaigns.
Concerning mortality, 3,347 (2,751 males and 596
females) deaths occurred in the 18 years we studied.
Standardized mortality rates were considerably inferior
in women. Considering the age-class mortality trend, a
natural increase in relation to age was observed in both
sexes, with peaks after the eighth decade of life and with
a slight increase between 1992 and 2010 (Table 2). Stan-
dardized mortality rates increased in Sassari province in
the years under investigation, as opposed to global
national figures which evidenced a steady decrement of
mortality rates in males in the last 2 decades (−2.2% per
year) and a continuous increment in females (+1% per
year) [7].
Finally, the relative 5 years survival from diagnosis was
low in both sexes (10%), but in accordance with percent-
ages published for other developed countries and for the
entire country [14]. Several factors impact on such low
survival in patients with lung cancer such as the lack
of effective screening programs, non-specific clinical
manifestations, delays in diagnosis, high percentage of ad-
vanced stages at diagnosis, smoking related comorbidities,ineffectiveness of current therapeutic strategies, and
others. The relative 5 years survival was better in women,
but the gap observed between sexes will probably decrease
in the future as a consequence of the steadily increasing
smoking incidences in women [2,9]. The current gap may
depend on several factors, other than smoking habits, like
biological dissimilarities or differences in histology, stage
and therapy. Globally, the relative 5-years survival im-
proved in our cohort from 1992 to 2010.
Conclusions
Our data showed an increasing trend in incidence of
lung cancer in women in North Sardinia in the last
decades. Conversely, a reduction of incidence rates was
observed in males. Furthermore, a slightly increasing
trend in mortality rates was observed in both sexes,
suggesting the need to enhance smoking control stra-
tegies, consider adoption of effective surveillance pol-
icies, and improve diagnosis and treatment methods.
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